Ligand Pharmaceuticals Inc. (OQ:LGND)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for LGND within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 26th, 2022
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 22/22 Sep 16/22 Higgins John L Direct Ownership Common Stock S - Open market or private sale -1,000 $88.06
Sep 16/22 Sep 16/22 Higgins John L Direct Ownership Common Stock S - Open market or private sale -3,000 $89.35
Sep 16/22 Sep 15/22 Higgins John L Direct Ownership Common Stock S - Open market or private sale -2,000 $90.00
Jul 6/22 Jun 30/22 Korenberg Matthew E Direct Ownership Common Stock J - Other transaction 164 $75.84
Jul 6/22 Jun 30/22 Higgins John L Direct Ownership Common Stock J - Other transaction 164 $75.84
Jun 30/22 Jun 29/22 Haas Jason Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 5,907  
Jun 30/22 Jun 29/22 Haas Jason Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,750  
Jun 14/22 Jun 10/22 Sabba Stephen L Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) -4,340  
Jun 14/22 Jun 10/22 Sabba Stephen L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,004  
Jun 14/22 Jun 10/22 Berkman Charles S Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 5,375  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for LGND within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 26th, 2022
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 22/22 Sep 16/22 Higgins John L Direct Ownership Common Stock S - Open market or private sale -1,000 $88.06
Sep 16/22 Sep 16/22 Higgins John L Direct Ownership Common Stock S - Open market or private sale -3,000 $89.35
Sep 16/22 Sep 15/22 Higgins John L Direct Ownership Common Stock S - Open market or private sale -2,000 $90.00
Jul 6/22 Jun 30/22 Korenberg Matthew E Direct Ownership Common Stock J - Other transaction 164 $75.84
Jul 6/22 Jun 30/22 Higgins John L Direct Ownership Common Stock J - Other transaction 164 $75.84
Jun 30/22 Jun 29/22 Haas Jason Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 5,907  
Jun 30/22 Jun 29/22 Haas Jason Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,750  
Jun 14/22 Jun 10/22 Sabba Stephen L Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) -4,340  
Jun 14/22 Jun 10/22 Sabba Stephen L Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,004  
Jun 14/22 Jun 10/22 Berkman Charles S Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 5,375  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $LGND

Competitors

Competitors with Recent Insider Filings
Moderna (OQ:MRNA)
Medpace Holdings (OQ:MEDP)
United Therapeutics (OQ:UTHR)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.